Lexaria Bioscience financials at a glance
| Year | Year | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.01M | $0.04M | $0.06M | $0.43M | $0.22M | $0.31M | $0.72M | $0.26M | $0.23M | $0.00M |
| GM % | Gross Margin % |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -103.26% | -120.19% | -54.56% | 91.19% | 86.49% | 68.43% | 75.74% | 71.87% | 86.07% | 0.00% |
| OM | Operating Margin |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | Earnings Per Share |
|
$-2.79 | $-1.26 | $-1.24 | $-1.01 | $0.00 | |||||||||||||
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sha. | Shares |
|
0.16m | 0.22m | 0.22m | 0.45m | 0.48m | 0.57m | 0.6m | 0.62m | 1.27m | 1.48m | 1.83m | 2.32m | 2.57m | 2.69m | 3m | 5.68m | 5.95m | 10.28m |
| OCF | Operating Cash Flow |
|
$0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $-0.62M | $-1.50M | $-0.66M | $-1.55M | $-2.52M | $-3.01M | $-2.62M | $-3.99M | $-4.88M | $-5.88M | $0.00M |
| FCF | Free Cash Flow |
|
$0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $-0.70M | $0.00M | $0.00M | $0.00M | $-2.59M | $-3.65M | $0.00M | $-4.07M | $-4.93M | $-5.91M | $0.00M |
| FCFS | Free Cash Flow Per Share |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.82 | $-1.16 | $-0.47 | $-0.79 | $-1.10 | $-1.46 | $-0.96 | $-0.93 | $-0.86 | $-0.91 | $0.00 |